Medizinische Universität Graz - Research portal
Publications
Search Items: MESOTHELIOMA - PATHOLOGY , . hits: 14
2022
Rüschoff, JH; Haberecker, M; Tsourti, Z; Nackaerts, K; de, Perrot, M; Brcic, L; Nadal, E; Tsimpoukis, S; Gray, SG; Ampollini, L; Aerts, JG; Felley-Bosco, E; Kirschner, MB; Monkhorst, K; Weynand, B; Bavaghar-Zaeimi, F; Samarzija, M; Llatjos, R; Finn, SP; Silini, E; von, der, Thüsen, J; Marti, N; Vervita, K; Kammler, R; Peters, S; Stahel, RA; Baas, P; Opitz, I, , ETOP, Mesoscape, consortium
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol. 2022; 35(12):1888-1899
Doi: 10.1038/s41379-022-01145-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Davidson, B; Pinamonti, M; Cuevas, D; Holth, A; Zeppa, P; Hager, T; Wohlschlaeger, J; Tötsch, M
The diagnostic role of PTEN and ARID1A in serous effusions.
Virchows Arch. 2018; 472(3):425-432
Doi: 10.1007/s00428-017-2273-1
Web of Science
PubMed
FullText
FullText_MUG
Davidson, B; Tötsch, M; Wohlschlaeger, J; Hager, T; Pinamonti, M
The diagnostic role of BAP1 in serous effusions.
Hum Pathol. 2018; 79(6):122-126
Doi: 10.1016/j.humpath.2018.05.012
Web of Science
PubMed
FullText
FullText_MUG
2016
Geltner, C; Errhalt, P; Baumgartner, B; Ambrosch, G; Machan, B; Eckmayr, J; Klikovits, T; Hoda, MA; Popper, H; Klepetko, W; Austrian Mesothelioma Interest Group (AMIG)
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Wien Klin Wochenschr. 2016; 128(17-18):611-617
Doi: 10.1007/s00508-016-1080-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73
Doi: 10.1016/j.ejca.2016.04.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Ghanim, B; Klikovits, T; Hoda, MA; Lang, G; Szirtes, I; Setinek, U; Rozsas, A; Renyi-Vamos, F; Laszlo, V; Grusch, M; Filipits, M; Scheed, A; Jakopovic, M; Samarzija, M; Brcic, L; Stancic-Rokotov, D; Kern, I; Rozman, A; Dekan, G; Klepetko, W; Berger, W; Glasz, T; Dome, B; Hegedus, B
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
Br J Cancer. 2015; 112(5): 783-792.
Doi: 10.1038/bjc.2015.9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Laszlo, V; Hoda, MA; Garay, T; Pirker, C; Ghanim, B; Klikovits, T; Dong, YW; Rozsas, A; Kenessey, I; Szirtes, I; Grusch, M; Jakopovic, M; Samarzija, M; Brcic, L; Kern, I; Rozman, A; Popper, H; Zöchbauer-Müller, S; Heller, G; Altenberger, C; Ziegler, B; Klepetko, W; Berger, W; Dome, B; Hegedus, B
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
J Pathol. 2015; 237(2):203-214
Doi: 10.1002/path.4567
Web of Science
PubMed
FullText
FullText_MUG
2014
Arzt, L; Quehenberger, F; Halbwedl, I; Mairinger, T; Popper, HH
BAP1 protein is a progression factor in malignant pleural mesothelioma.
Pathol Oncol Res. 2014; 20(1):145-151
Doi: 10.1007/s12253-013-9677-2
Web of Science
PubMed
FullText
FullText_MUG
Brčić, L; Jakopović, M; Brčić, I; Klarić, V; Milošević, M; Sepac, A; Samaržija, M; Seiwerth, S
Reproducibility of histological subtyping of malignant pleural mesothelioma.
Virchows Arch. 2014; 465(6): 679-685.
Doi: 10.1007/s00428-014-1664-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Lindenmann, J; Matzi, V; Neuboeck, N; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM
Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
Interact Cardiovasc Thorac Surg. 2013; 16(3):237-243
Doi: 10.1093/icvts/ivs465
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Hoda, MA; Münzker, J; Ghanim, B; Schelch, K; Klikovits, T; Laszlo, V; Sahin, E; Bedeir, A; Lackner, A; Dome, B; Setinek, U; Filipits, M; Eisenbauer, M; Kenessey, I; Török, S; Garay, T; Hegedus, B; Catania, A; Taghavi, S; Klepetko, W; Berger, W; Grusch, M
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.
Br J Cancer. 2012; 107(12):1978-1986
Doi: 10.1038/bjc.2012.519
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wiesner, T; Fried, I; Ulz, P; Stacher, E; Popper, H; Murali, R; Kutzner, H; Lax, S; Smolle-Jüttner, F; Geigl, JB; Speicher, MR
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.
J Clin Oncol. 2012; 30(32):e337-e340
Doi: 10.1200/JCO.2011.41.2965
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1994
Szolar, DH; Preidler, KW; Kugler, C; Hausegger, K; Klein, GE; Popper, H; Fladerer, J; Kaufmann, N; Schreyer, H
Fluoroscopically guided percutaneous fine-needle biopsy of the lung using the ROTEX needle: results in 890 patients with focal lung lesions
FORTSCHR RONTGENSTRAHL NEUEN. 1994; 161(6): 505-511.
Web of Science
PubMed
1979
Höfler, H; Schmid, P; Tscheliessnigg, KH
Malignant angioblastic mesothelioma of the pericardium (author's transl)
Zentralbl Allg Pathol. 1979; 123(4): 344-350.
(- Case Report)
PubMed